750 related articles for article (PubMed ID: 12424695)
21. Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development.
Mischitelli M; Fioriti D; Videtta M; Degener AM; Antinori A; Cinque P; Giordano A; Pietropaolo V
J Cell Physiol; 2005 Sep; 204(3):913-8. PubMed ID: 15828018
[TBL] [Abstract][Full Text] [Related]
22. JC virus type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in urine from controls.
Agostini HT; Ryschkewitsch CF; Singer EJ; Baumhefner RW; Stoner GL
J Hum Virol; 1998; 1(3):200-6. PubMed ID: 10195243
[TBL] [Abstract][Full Text] [Related]
23. Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis.
Aksamit AJ
Microsc Res Tech; 1995 Nov; 32(4):302-11. PubMed ID: 8573780
[TBL] [Abstract][Full Text] [Related]
24. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa.
Glass AJ; Venter M
J Med Virol; 2009 Nov; 81(11):1929-37. PubMed ID: 19774679
[TBL] [Abstract][Full Text] [Related]
25. History and current concepts in the pathogenesis of PML.
Major EO
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S3-7. PubMed ID: 22123932
[TBL] [Abstract][Full Text] [Related]
26. Reactivation of human polyomavirus JC in patients affected by psoriasis vulgaris and psoriatic arthritis and treated with biological drugs: preliminary results.
Nardis C; Anzivino E; Bellizzi A; Rodio DM; De Pità O; Chiarini F; Pietropaolo V
J Cell Physiol; 2012 Dec; 227(12):3796-802. PubMed ID: 22422468
[TBL] [Abstract][Full Text] [Related]
27. [Progressive multifocal leukoencephalopathy. Demyelinating viral disease--common complication of AIDS].
Aström KE
Lakartidningen; 2001 Sep; 98(39):4206-11, 4213. PubMed ID: 11680156
[TBL] [Abstract][Full Text] [Related]
28. Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain.
Okada Y; Sawa H; Endo S; Orba Y; Umemura T; Nishihara H; Stan AC; Tanaka S; Takahashi H; Nagashima K
Acta Neuropathol; 2002 Aug; 104(2):130-6. PubMed ID: 12111355
[TBL] [Abstract][Full Text] [Related]
29. An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice.
Matoba T; Orba Y; Suzuki T; Makino Y; Shichinohe H; Kuroda S; Ochiya T; Itoh H; Tanaka S; Nagashima K; Sawa H
Neuropathology; 2008 Jun; 28(3):286-94. PubMed ID: 18179406
[TBL] [Abstract][Full Text] [Related]
30. [Progressive multifocal leukoencephalopathy: virological and neuropathological aspects].
Ingrand D; Gray F
Arch Anat Cytol Pathol; 1997; 45(2-3):127-34. PubMed ID: 9382604
[TBL] [Abstract][Full Text] [Related]
31. Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells.
Chang CF; Otte J; Kerr DA; Välkkilä M; Calkins CE; Khalili K
Virology; 1996 Jul; 221(1):226-31. PubMed ID: 8661431
[TBL] [Abstract][Full Text] [Related]
32. JC virus DNA in cerebrospinal fluid samples from Brazilian AIDS patients with focal brain lesions without mass effect.
Fink MC; Penalva de Oliveira AC; Milagres FA; Vidal JE; Picerno-Pouza AF; Duarte Neto A; Pannuti CS
J Infect; 2006 Jan; 52(1):30-6. PubMed ID: 16368458
[TBL] [Abstract][Full Text] [Related]
33. High expression of MeCP2 in JC virus-infected cells of progressive multifocal leukoencephalopathy brains.
Shirai S; Takahashi K; Kohsaka S; Tsukamoto T; Isogai H; Kudo S; Sawa H; Nagashima K; Tanaka S
Neuropathology; 2011 Feb; 31(1):38-41. PubMed ID: 20497345
[TBL] [Abstract][Full Text] [Related]
34. Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.
O'Neill FJ; Greenlee JE; Dörries K; Clawson SA; Carney H
J Neurovirol; 2003 Oct; 9(5):567-76. PubMed ID: 13129771
[TBL] [Abstract][Full Text] [Related]
35. Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.
Delbue S; Branchetti E; Boldorini R; Vago L; Zerbi P; Veggiani C; Tremolada S; Ferrante P
J Med Virol; 2008 Dec; 80(12):2147-52. PubMed ID: 19040292
[TBL] [Abstract][Full Text] [Related]
36. [Genetic changes in JC virus possibly associated with progressive multifocal leukoencephalopathy].
Yogo Y; Sugimoto C; Zheng HY; Kitamura T
No To Shinkei; 2007 Feb; 59(2):109-18. PubMed ID: 17315752
[TBL] [Abstract][Full Text] [Related]
37. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
38. Animal Models for Progressive Multifocal Leukoencephalopathy.
White MK; Gordon J; Berger JR; Khalili K
J Cell Physiol; 2015 Dec; 230(12):2869-74. PubMed ID: 26041694
[TBL] [Abstract][Full Text] [Related]
39. Development and utilization of a quantitative polymerase chain reaction assay to evaluate human polyomavirus JC DNA load.
Cavallo R; Bergallo M; Costa C; Piana F; Burdino E; Merlino C; Negro Ponzi A
Panminerva Med; 2006 Mar; 48(1):59-66. PubMed ID: 16633333
[TBL] [Abstract][Full Text] [Related]
40. Broad distribution of the JC virus receptor contrasts with a marked cellular restriction of virus replication.
Suzuki S; Sawa H; Komagome R; Orba Y; Yamada M; Okada Y; Ishida Y; Nishihara H; Tanaka S; Nagashima K
Virology; 2001 Jul; 286(1):100-12. PubMed ID: 11448163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
